Advances in adult asthma 2006: Its risk factors, course, and management

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 3, 2007, Pages 563-566

  Apter, Andrea J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adherence; adults; Asthma; health disparities; therapeutics

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE; IMMUNOGLOBULIN E; NITRIC OXIDE; SALMETEROL; SEX HORMONE;

ASTHMA; CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADULT; ASTHMA; HUMANS; RISK FACTORS;

EID: 33847252849     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.01.001     Document Type: Review

References (49)

1. Apter A.J., and Szefler S.J. Advances in adult and pediatric asthma. J Allergy Clin Immunol 117 (2006) 512-518
2. Apter A.J., and Szefler S.J. Advances in adult and pediatric asthma. J Allergy Clin Immunol 113 (2004) 407-414
3. Szefler S.J., and Apter A. Advances in pediatric and adult asthma. J Allergy Clin Immunol 115 (2005) 470-477
4. Szefler S. Advances in pediatric asthma 2006. J Allergy Clin Immunol 119 (2007) 558-562
5. Reed C.E. The natural history of asthma. J Allergy Clin Immunol 118 (2006) 543-548
6. Jaakkola J.J., Ahmed P., Ieromnimon A., Goepfert P., Laiou E., Quansah R., et al. Preterm delivery and asthma: a systematic review and meta-analysis. J Allergy Clin Immunol 118 (2006) 823-830
7. Salam M.T., Wenten M., and Gilliland F.D. Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. J Allergy Clin Immunol 117 (2006) 1001-1007
8. Stenius-Aarniala B., Poussa T., Kvarnstrom J., Gronlund E.L., Ylikahri M., and Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 320 (2000) 827-832
9. Chinn S., Downs S.H., Anto J.M., Gerbase M.W., Leynaert B., de Marco R., et al. Incidence of asthma and net change in symptoms in relation to changes in obesity. Eur Respir J 28 (2006) 763-771
10. Chinn S., Jarvis D., and Burney P. Relation of bronchial responsiveness to body mass index in the ECRHS. European Community Respiratory Health Survey. Thorax 57 (2002) 1028-1033
11. Schachter L.M., Peat J.K., and Salome C.M. Asthma and atopy in overweight children. Thorax 58 (2003) 1031-1035
12. Flaherman V., and Rutherford G.W. A meta-analysis of the effect of high weight on asthma. Arch Dis Child 91 (2006) 334-339
13. Barros R., Moreira A., Fonseca J., Moreira P., Fernandes L., de Oliveira J.F., et al. Obesity and airway inflammation in asthma. J Allergy Clin Immunol 117 (2006) 1501-1502
14. Matsuda K., Nishi Y., Okamatsu Y., Kojima M., and Matsuishi T. Ghrelin and leptin: a link between obesity and allergy?. J Allergy Clin Immunol 117 (2006) 705-706
15. Shore S.A., Terry R.D., Flynt L., Xu A., and Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 118 (2006) 389-395
16. Shore S.A., and Fredberg J.J. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol 115 (2005) 925-927
17. Shore S.A., Schwartzman I.N., Mellema M.S., Flynt L., Imrich A., and Johnston R.A. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol 115 (2005) 103-109
18. Hallstrand T.S., Fischer M.E., Wurfel M.M., Afari N., Buchwald D., and Goldberg J. Genetic pleiotropy between asthma and obesity in a community-based sample of twins. J Allergy Clin Immunol 116 (2005) 1235-1241
19. Ford E.S. The epidemiology of obesity and asthma. J Allergy Clin Immunol 115 (2005) 897-909
20. Appleton S., Adams R.J., Wilson D.H., Taylor A.W., and Ruffin R.E. Central obesity is associated with non-atopic but not atopic asthma in a representative patient sample. J Allergy Clin Immunol 118 (2006) 1284-1291
21. Apter A.J. The influence of health disparities on individual patient outcomes: what is the link between genes and environment?. J Allergy Clin Immunol 117 (2006) 345-350
22. In: Smedley B., Stith A.Y., and Nelson A.R. (Eds). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (2003), Institute of Medicine, National Academies Press, Washington, DC
23. Joseph C.L., Williams L.K., Ownby D.R., Saltzgaber J., and Johnson C.C. Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma. J Allergy Clin Immunol 117 (2006) 233-240
24. Barnes K.C. Genetic epidemiology of health disparities in allergy and clinical immunology. J Allergy Clin Immunol 117 (2006) 243-254
25. Gupta R.S., Carrion-Carire V., and Weiss K.B. The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol 117 (2006) 351-358
26. Arbes Jr. S.J., Sever M.L., Vaughn B., Cohen E.A., and Zeldin D.C. Oral pathogens and allergic disease: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 118 (2006) 1169-1175
27. Flohr C., Tuen L., Lewis S., Quinnell R., Minh T., Liem H., et al. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: a cross-sectional study. J Allergy Clin Immunol 118 (2006) 1305-1311
28. Radon K., and Schulze A. Adult obesity, farm childhood and their effect on allergic sensitization. J Allergy Clin Immunol 118 (2006) 1279-1283
29. Gold D.R. Allergy: the price paid for longevity and social wealth?. J Allergy Clin Immunol 117 (2006) 148-150
30. Hennekens C.H., and Buring J.E. Analysis of epidemiologic studies: evaluating the role of bias. Epidemiology in Medicine (1987), Little, Brown and Company, Boston (MA) 272-286
31. Rothman K.J. Biases in study design. Epidemiology, An Introduction (2002), Oxford University Press, Oxford 94-112
32. Nathan R.A., Sorkness C.A., Kosinski M., Schatz M., Li J.T., Marcus P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
33. Schatz M., Sorkness C.A., Li J.T., Marcus P., Murray J.J., Nathan R.A., et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 117 (2006) 549-556
34. Deykin A. Biomarker-driven care in asthma: are we there?. J Allergy Clin Immunol 118 (2006) 565-568
35. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
36. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
37. Hargreave F.E., and Parameswaran K. Problems with using exhaled nitric oxide to guide asthma treatment. J Allergy Clin Immunol 117 (2006) 1511 author reply 1512
38. Cockcroft D.W., and Davis B.E. The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result. J Allergy Clin Immunol 117 (2006) 1244-1248
39. Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., and Dorinsky P.M. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
40. Nelson H.S. Is there a problem with inhaled long-acting beta-adrenergic agonists?. J Allergy Clin Immunol 117 (2006) 3-16
41. Szefler S.J., Whelan G.J., and Leung D.Y. "Black box" warning: wake-up call or overreaction?. J Allergy Clin Immunol 117 (2006) 26-29
42. Pearlman D.S. Primum non nocere and "black box" warnings. J Allergy Clin Immunol 117 (2006) 30-31
43. Murphy S., and Roberts R. "Black box" 101: how the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk. J Allergy Clin Immunol 117 (2006) 34-39
44. Aaronson D.W. The "black box" warning and allergy drugs. J Allergy Clin Immunol 117 (2006) 40-44
45. Anderson S.D., Sue-Chu M., Perry C.P., Gratziou C., Kippelen P., McKenzie D.C., et al. Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics. J Allergy Clin Immunol 117 (2006) 767-773
46. Williams L.K., Pladevall M., Xi H., Peterson E.L., Joseph C., Lafata J.E., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 114 (2004) 1288-1293
47. Bender B.G., Pedan A., and Varasteh L.T. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 118 (2006) 899-904
48. Marceau C., Lemiere C., Berbiche D., Perreault S., and Blais L. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol 118 (2006) 574-581
49. Fuhlbrigge A.L., Bae S.J., Weiss S.T., Kuntz K.M., and Paltiel A.D. Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density. J Allergy Clin Immunol 117 (2006) 359-366